Dextroamphetamine Sulfate 11534-0189
Product NDC
11534-0189- Manufacturer
- Sunrise Pharmaceutical, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- July 4, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA210059
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dextroamphetamine Sulfate | 10 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Packaging Options(2)
100 TABLET in 1 BOTTLE (11534-189-01)
1000 TABLET in 1 BOTTLE (11534-189-03)